ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 221 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2021. The put-call ratio across all filers is 4.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,195,096 | +112324.2% | 243,158 | +7.8% | 0.01% | – |
Q2 2023 | $2,842 | -99.9% | 225,582 | +22.3% | 0.00% | -100.0% |
Q1 2023 | $2,406,785 | -20.3% | 184,428 | +7.8% | 0.00% | -33.3% |
Q4 2022 | $3,018,557 | +108.5% | 171,120 | +80.0% | 0.01% | +100.0% |
Q3 2022 | $1,448,000 | +58.4% | 95,061 | +54.2% | 0.00% | +200.0% |
Q2 2022 | $914,000 | -22.6% | 61,640 | +17.6% | 0.00% | 0.0% |
Q1 2022 | $1,181,000 | +56.6% | 52,425 | +28.3% | 0.00% | 0.0% |
Q4 2021 | $754,000 | -78.5% | 40,874 | -84.4% | 0.00% | -66.7% |
Q3 2021 | $3,502,000 | -30.0% | 261,897 | -3.1% | 0.00% | -25.0% |
Q2 2021 | $5,002,000 | +208.0% | 270,237 | +149.8% | 0.00% | +100.0% |
Q1 2021 | $1,624,000 | -3.2% | 108,181 | -36.7% | 0.00% | 0.0% |
Q4 2019 | $1,678,000 | +206.8% | 170,982 | +344.9% | 0.00% | – |
Q3 2018 | $547,000 | +21.6% | 38,428 | +2.5% | 0.00% | – |
Q2 2018 | $450,000 | -92.0% | 37,477 | -91.7% | 0.00% | -100.0% |
Q1 2018 | $5,592,000 | -14.1% | 452,847 | +1.2% | 0.01% | 0.0% |
Q4 2017 | $6,512,000 | +22.6% | 447,560 | +19.9% | 0.01% | 0.0% |
Q3 2017 | $5,311,000 | +11.0% | 373,256 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $4,785,000 | -41.2% | 373,256 | -41.9% | 0.01% | -37.5% |
Q1 2017 | $8,142,000 | +4.2% | 642,097 | -16.1% | 0.01% | +14.3% |
Q4 2016 | $7,815,000 | +66.1% | 765,428 | +110.0% | 0.01% | +40.0% |
Q3 2016 | $4,706,000 | +3261.4% | 364,530 | +3193.0% | 0.01% | – |
Q2 2016 | $140,000 | -99.1% | 11,070 | -99.0% | 0.00% | -100.0% |
Q1 2016 | $14,950,000 | +118.9% | 1,131,724 | +154.9% | 0.02% | +112.5% |
Q4 2015 | $6,829,000 | +80.9% | 444,006 | +57.7% | 0.01% | +60.0% |
Q3 2014 | $3,776,000 | -13.8% | 281,475 | +3.1% | 0.01% | 0.0% |
Q2 2014 | $4,380,000 | -13.0% | 272,920 | -2.3% | 0.01% | -16.7% |
Q1 2014 | $5,037,000 | -62.3% | 279,345 | -67.7% | 0.01% | -64.7% |
Q4 2013 | $13,350,000 | +1.9% | 863,510 | -2.0% | 0.02% | 0.0% |
Q3 2013 | $13,101,000 | +15.7% | 881,055 | +0.7% | 0.02% | +6.2% |
Q2 2013 | $11,320,000 | – | 874,830 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |